## Background Long-term survival of patients with hepatocellular carcinoma (HCC) after liver transplantation is affected mainly by recurrence of HCC. There is the opinion that the chance of recurrence after 2Β years post-transplantation is remote, and therefore lifelong surveillance is not justified
Recurrence-free survival after liver transplantation for small hepatocellular carcinoma
β Scribed by W. O. Bechstein; O. Guckelberger; N. Kling; N. Rayes; S. G. Tullius; H. Lobeck; T. Vogl; S. Jonas; P. Neuhaus
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 145 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The actual impact of transarterial chemoembolization before liver transplantation (LT) for hepatocellular carcinoma (HCC) on patient survival and HCC recurrence is not known. Between 1985 and 1998, 479 patients with HCC in 14 French centers were evaluated for LT. Among these 479 patients, this case-
Liver transplantation is regarded as an effective treatment for early hepatocellular carcinoma (HCC). However, some patients experience recurrence and subsequently rapid progression of the disease. We investigated prognostic factors affecting survival after recurrence in patients who underwent adult
In regions with a limited deceased donor pool, living donor adult liver transplantation (LDALT) has become an important treatment modality for patients with hepatocellular carcinoma (HCC) and cirrhosis. Studies have shown higher recurrence rates of HCC after LDALT in comparison with deceased donor l